Literature DB >> 20308516

Medullary thyroid carcinoma: comparison with papillary thyroid carcinoma and application of current sonographic criteria.

Sanghee Lee1, Jung Hee Shin, Boo-Kyung Han, Eun Young Ko.   

Abstract

OBJECTIVE: The aim of this study was to evaluate whether sonography can diagnose medullary thyroid carcinoma (MTC) as a malignant lesion using widely accepted sonographic criteria and to compare which sonographic findings of MTC are different from findings for papillary thyroid carcinoma (PTC).
MATERIALS AND METHODS: The study included 42 patients (13 men and 29 women; mean age, 48 years) with 46 MTCs and 51 consecutive patients (10 men and 41 women; mean age, 48 years) with 55 PTCs that were confirmed at surgery. Two radiologists retrospectively determined the sonographic diagnoses according to malignant criteria (a taller-than-wide shape, spiculated margin, marked hypoechogenicity, and microcalcifications or macrocalcifications) and compared the sonographic findings of MTCs and PTCs.
RESULTS: MTCs were diagnosed as malignant for 72% of cases by sonography, whereas PTCs were 87% malignant (p = 0.0511). Compared with PTCs, MTCs were larger (mean size, 2.3 +/- 1.5 cm vs 1.1 +/- 1.1 cm) (p = 0.001; odds ratio [OR], 3.84; 95% CI, 1.719-8.565), more frequently showed the presence of a cystic change (33% vs 4%) (p = 0.0226; OR, 0.10; 95% CI, 0.014-0.725), and more commonly showed homogeneous echotexture of the solid portion (59% vs 31%) (p = 0.0004; OR, 0.08; 95% CI, 0.019-0.321). MTCs tended to show an oval shape and circumscribed margin, but there was no statistical significance in multivariate analysis. There were no significant differences in echogenicity, presence, and type of calcification for MTCs and PTCs.
CONCLUSION: Currently accepted sonographic criteria can be applied for a diagnosis of MTCs. MTCs differ from PTCs in size, presence of a cystic change, and echotexture.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20308516     DOI: 10.2214/AJR.09.3276

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  18 in total

Review 1.  Surgical management of medullary thyroid carcinoma.

Authors:  Agathoklis Konstantinidis; Michael Stang; Sanziana A Roman; Julie Ann Sosa
Journal:  Updates Surg       Date:  2017-04-13

Review 2.  [Imaging of medullary thyroid carcinoma].

Authors:  M Uhrig; S Delorme
Journal:  Radiologe       Date:  2019-11       Impact factor: 0.635

Review 3.  Clinical review: Incidentally discovered medullary thyroid cancer: diagnostic strategies and treatment.

Authors:  Shabina R Ahmed; Douglas W Ball
Journal:  J Clin Endocrinol Metab       Date:  2011-02-23       Impact factor: 5.958

4.  Medullary thyroid carcinoma: Application of Thyroid Imaging Reporting and Data System (TI-RADS) Classification.

Authors:  Gabin Yun; Yeo Koon Kim; Sang Il Choi; Ji-Hoon Kim
Journal:  Endocrine       Date:  2018-04-21       Impact factor: 3.633

5.  Ultrasonography should not guide the timing of thyroidectomy in pediatric patients diagnosed with multiple endocrine neoplasia syndrome 2A through genetic screening.

Authors:  Lilah F Morris; Steven G Waguespack; Beth S Edeiken-Monroe; Jeff E Lee; Thereasa A Rich; Anita K Ying; Carla L Warneke; Douglas B Evans; Nancy D Perrier; Elizabeth G Grubbs
Journal:  Ann Surg Oncol       Date:  2012-08-14       Impact factor: 5.344

Review 6.  New American Thyroid Association Sonographic Patterns for Thyroid Nodules Perform Well in Medullary Thyroid Carcinoma: Institutional Experience, Systematic Review, and Meta-Analysis.

Authors:  Pablo Valderrabano; Donald L Klippenstein; John B Tourtelot; Zhenjun Ma; Zachary J Thompson; Howard S Lilienfeld; Bryan McIver
Journal:  Thyroid       Date:  2016-07-08       Impact factor: 6.568

7.  Ultrasound features of medullary thyroid carcinoma correlate with cancer aggressiveness: a retrospective multicenter study.

Authors:  Pierpaolo Trimboli; Luca Giovanella; Stefano Valabrega; Massimiliano Andrioli; Roberto Baldelli; Nadia Cremonini; Fabio Rossi; Leo Guidobaldi; Agnese Barnabei; Francesca Rota; Antonella Paoloni; Laura Rizza; Giorgio Fattorini; Maurizio Latini; Claudio Ventura; Paolo Falasca; Fabio Orlandi; Anna Crescenzi; Ferdinando D'Ambrosio; Vito Cantisani; Francesco Romanelli; Roberto Negro; Enrico Saggiorato; Marialuisa Appetecchia
Journal:  J Exp Clin Cancer Res       Date:  2014-10-25

8.  Metastatic Medullary Thyroid Carcinoma and Cabozantinib: Case Series and Review of Literature.

Authors:  Sakshi Kapur; Han Xiao; Maureen F Zakowski; Meera R Hameed; Miles B Levin
Journal:  World J Oncol       Date:  2014-05-06

9.  Ultrasonographic characteristics of medullary thyroid carcinoma: a comparison with papillary thyroid carcinoma.

Authors:  Mei-Juan Liu; Zhong-Feng Liu; Yuan-Yuan Hou; Yan-Ming Men; Yu-Xi Zhang; Ling-Yun Gao; Hao Liu
Journal:  Oncotarget       Date:  2017-04-18

10.  Clinical value of color Doppler ultrasound combined with serum tumor markers for the diagnosis of medullary thyroid carcinoma.

Authors:  Xue Yang; Jinjuan Xu; Jilan Sun; Lizhi Yin; Rui Guo; Zhimei Yan
Journal:  Oncol Lett       Date:  2021-05-27       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.